+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Multivalent Oral Rotavirus Vaccine Market - Global Forecast 2025-2030- Product Image
Multivalent Oral Rotavirus Vaccine Market - Global Forecast 2025-2030- Product Image
Sale

Multivalent Oral Rotavirus Vaccine Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 191 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6123814
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The multivalent oral rotavirus vaccine market is entering a phase of accelerated innovation and strategic evolution, marked by advances in formulation technology, regulatory flexibility, and broader geographic reach. Senior decision-makers are navigating persistent global health challenges and changing trade landscapes as the demand for advanced vaccines expands.

Market Snapshot: Multivalent Oral Rotavirus Vaccine

The global multivalent oral rotavirus vaccine market continues to be propelled by the critical need to address severe gastroenteritis in children under five. As evolving viral strains, logistical barriers, and varying regional needs drive the industry, recent years have seen a transformation in scientific and commercial strategies. Notably, the market is responding to shifts in antigen presentation, adjuvant optimization, and streamlined clinical pathways, which are all enhancing vaccine efficacy while supporting speed-to-market for new candidates. This sector also faces new trade and tariff conditions set to come into effect in 2025, influencing procurement, manufacturing, and distribution strategies for both established and emerging regions.

Scope & Segmentation

  • Vaccine Type: Monovalent and pentavalent oral rotavirus vaccines targeting broad serotype coverage.
  • Dosage Form: Liquid oral suspensions for ease of use in large campaigns alongside lyophilized powders offering extended shelf life and reduced cold chain demands.
  • Distribution Channel: Multiple strategies including hospital pharmacies, online pharmacies (via web and mobile platforms), and retail pharmacies (chain and independent outlets).
  • End User: Hospitals (private and public), pediatric clinics (group and solo practices), and public health programs with distinct procurement patterns.
  • Age Group: Infants under six months, children six to twelve months, and those over one year.
  • Regional Coverage: Analysis spans the Americas (United States, Canada, Mexico, Brazil, Argentina), EMEA (UK, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), and Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Leading Innovators: Key market participants such as Merck & Co., Inc. and Serum Institute of India Pvt. Ltd. are profiled on research, manufacturing, and partnership dynamics.

Key Takeaways

  • Next-generation multivalent oral rotavirus vaccines offer improved immunogenicity and thermotolerance, directly responding to global strain variability and logistical constraints.
  • Accelerated clinical trial timelines and flexible regulatory strategies are enabling faster approvals, particularly benefitting both established and developing markets.
  • Digital health platforms support real-world evidence capture and pharmacovigilance initiatives, driving better post-marketing monitoring and outcome measurement.
  • Strategic partnerships, public-private alliances, and investment in manufacturing infrastructure are expanding vaccine access and addressing supply chain challenges.
  • Distribution is diversifying, with increased use of online channels and hybrid delivery models to maximise reach in both urban and underserved regions.

Tariff Impact 2025

With United States tariffs scheduled for 2025, manufacturers relying on imported ingredients and specialized materials face increased production costs. This may lead to recalibration of procurement budgets and price negotiations in both domestic and global markets. Movement toward local production through technology transfer and joint ventures is likely, yet calls for significant investment and regulatory coordination. For global health programs, early policy engagement and diversified financing will be key to maintaining access and smooth distribution during periods of trade adjustment.

Primary Keyword Focus: Multivalent Oral Rotavirus Vaccine

This report offers an in-depth analysis of the multivalent oral rotavirus vaccine landscape, addressing scientific, regulatory, and market developments vital for informed investment and operational strategy.

Methodology & Data Sources

Findings are underpinned by a robust methodology combining peer-reviewed literature reviews, analysis of regulatory and patent filings, and comprehensive examination of health authority databases. Expert interviews across the development, regulatory, and distribution spectrum reinforce the depth and integrity of insights.

Why This Report Matters

  • Enables leaders to adapt to evolving regulatory pathways, optimize procurement, and structure commercial models amid changing global conditions.
  • Equips organizations to evaluate partnership opportunities, technology transfers, and new distribution paradigms for sustained market presence.
  • Supports evidence-backed decision-making as vaccination drives evolve, tariffs shift, and health system priorities change.

Conclusion

With the intersection of innovation, regional policy dynamics, and market adaptation, stakeholders in the multivalent oral rotavirus vaccine sector are positioned to drive significant public health impact. This comprehensive analysis provides actionable guidance for navigating emerging opportunities and global challenges.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Advancements in recombinant nanoparticle technology improving multivalent rotavirus vaccine immunogenicity
5.2. Integration of thermostable formulation strategies to enhance vaccine distribution in low-resource settings
5.3. Collaborative public-private partnerships accelerating multivalent oral rotavirus vaccine clinical trials
5.4. Regulatory harmonization efforts streamlining approval processes across different global regions
5.5. Adoption of next-generation sequencing for strain selection in quadrivalent vaccine development
5.6. Surging demand for affordable multivalent rotavirus vaccines driven by Gavi-supported immunization programs
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Multivalent Oral Rotavirus Vaccine Market, by Vaccine Type
8.1. Introduction
8.2. Vaccine Type
8.2.1. Monovalent
8.2.2. Pentavalent
9. Multivalent Oral Rotavirus Vaccine Market, by Dosage Form
9.1. Introduction
9.2. Dosage Form
9.2.1. Liquid Oral Suspension
9.2.2. Lyophilized Powder
10. Multivalent Oral Rotavirus Vaccine Market, by Distribution Channel
10.1. Introduction
10.2. Distribution Channel
10.2.1. Hospital Pharmacy
10.2.2. Online Pharmacy
10.2.2.1. Mobile App Based Platform
10.2.2.2. Web Based Platform
10.2.3. Retail Pharmacy
10.2.3.1. Chain Pharmacy
10.2.3.2. Independent Pharmacy
11. Multivalent Oral Rotavirus Vaccine Market, by End User
11.1. Introduction
11.2. End User
11.2.1. Hospitals
11.2.1.1. Private Hospitals
11.2.1.2. Public Hospitals
11.2.2. Pediatric Clinics
11.2.2.1. Group Practice
11.2.2.2. Solo Practice
11.2.3. Public Health Programs
12. Multivalent Oral Rotavirus Vaccine Market, by Age Group
12.1. Introduction
12.2. 6 to 12 Months
12.3. Over 12 Months
12.4. Under 6 Months
13. Americas Multivalent Oral Rotavirus Vaccine Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Multivalent Oral Rotavirus Vaccine Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Multivalent Oral Rotavirus Vaccine Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Merck & Co., Inc.
16.3.2. Serum Institute of India Pvt. Ltd.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 14. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET: RESEARCHAI
FIGURE 26. MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET: RESEARCHSTATISTICS
FIGURE 27. MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET: RESEARCHCONTACTS
FIGURE 28. MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY MONOVALENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY MONOVALENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY PENTAVALENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY PENTAVALENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DOSAGE FORM, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DOSAGE FORM, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY LIQUID ORAL SUSPENSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY LIQUID ORAL SUSPENSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY MOBILE APP BASED PLATFORM, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY MOBILE APP BASED PLATFORM, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY WEB BASED PLATFORM, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY WEB BASED PLATFORM, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY END USER, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY END USER, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY PEDIATRIC CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY PEDIATRIC CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY GROUP PRACTICE, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY GROUP PRACTICE, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY SOLO PRACTICE, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY SOLO PRACTICE, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY PEDIATRIC CLINICS, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY PEDIATRIC CLINICS, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY PUBLIC HEALTH PROGRAMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY PUBLIC HEALTH PROGRAMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY 6 TO 12 MONTHS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY 6 TO 12 MONTHS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY OVER 12 MONTHS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY OVER 12 MONTHS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY UNDER 6 MONTHS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY UNDER 6 MONTHS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY PEDIATRIC CLINICS, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY PEDIATRIC CLINICS, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY PEDIATRIC CLINICS, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY PEDIATRIC CLINICS, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 141. CANADA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 142. CANADA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 143. CANADA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 144. CANADA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 145. CANADA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 146. CANADA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 147. CANADA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 148. CANADA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 149. CANADA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 150. CANADA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 151. CANADA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 152. CANADA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 153. CANADA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 154. CANADA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 155. CANADA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 156. CANADA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 157. CANADA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. CANADA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. CANADA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 160. CANADA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 161. CANADA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 162. CANADA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 163. CANADA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY PEDIATRIC CLINICS, 2018-2024 (USD MILLION)
TABLE 164. CANADA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY PEDIATRIC CLINICS, 2025-2030 (USD MILLION)
TABLE 165. CANADA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 166. CANADA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 167. MEXICO MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 168. MEXICO MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 169. MEXICO MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 170. MEXICO MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 171. MEXICO MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 172. MEXICO MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 173. MEXICO MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 174. MEXICO MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 175. MEXICO MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 176. MEXICO MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 177. MEXICO MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 178. MEXICO MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 179. MEXICO MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 180. MEXICO MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 181. MEXICO MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 182. MEXICO MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 183. MEXICO MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 184. MEXICO MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 185. MEXICO MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 186. MEXICO MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 187. MEXICO MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 188. MEXICO MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 189. MEXICO MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY PEDIATRIC CLINICS, 2018-2024 (USD MILLION)
TABLE 190. MEXICO MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY PEDIATRIC CLINICS, 2025-2030 (USD MILLION)
TABLE 191. MEXICO MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 192. MEXICO MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY PEDIATRIC CLINICS, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY PEDIATRIC CLINICS, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY PEDIATRIC CLINICS, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY PEDIATRIC CLINICS, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY PEDIATRIC CLINICS, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY PEDIATRIC CLINICS, 2025-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 276. UNITED KINGDOM MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 278. UNITED KINGDOM MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 280. UNITED KINGDOM MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 282. UNITED KINGDOM MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 284. UNITED KINGDOM MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 286. UNITED KINGDOM MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 288. UNITED KINGDOM MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. UNITED KINGDOM MULTIVALENT ORAL ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MI

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Multivalent Oral Rotavirus Vaccine market report include:
  • Merck & Co., Inc.
  • Serum Institute of India Pvt. Ltd.

Related Topics

Related Reports

Rotavirus Vaccine Market - Global Forecast 2025-2030 - Product Image

Rotavirus Vaccine Market - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
Rotavirus Vaccine Market Report 2025 - Product Image

Rotavirus Vaccine Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Rotavirus Vaccines - Global Strategic Business Report - Product Image

Rotavirus Vaccines - Global Strategic Business Report

  • Report
  • 277 Pages
  • Global
From
Rotavirus Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Rotavirus Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Multivalent Vaccines Market 2024 - Product Image

Multivalent Vaccines Market 2024

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.